TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PCI Biotech Holding ASA
Closing information (x1000 SEK)
Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Turnover | 9,936 | 9,820 | 10,260 |
Financial expenses | 2,835 | 155 | 87 |
Earnings before taxes | -93,883 | -35,631 | -42,882 |
Total assets | 298,357 | 365,796 | 58,492 |
Current assets | 291,711 | 365,778 | 58,470 |
Current liabilities | 26,053 | 17,411 | 14,599 |
Equity capital | 269,580 | 348,275 | 41,882 |
- share capital | 118,268 | 114,223 | 75,033 |
Employees (average) | 0 | ||
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Solvency | 90.4% | 95.2% | 71.6% |
Turnover per employee | |||
Profit as a percentage of turnover | -944.9% | -362.8% | -418.0% |
Return on assets (ROA) | -30.5% | -9.7% | -73.2% |
Current ratio | 1119.7% | 2100.8% | 400.5% |
Return on equity (ROE) | -34.8% | -10.2% | -102.4% |
Change turnover | -204 | -681 | -225 |
Change turnover % | -2% | -6% | -2% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.